Table 2 Population study’s features
From: Distinguishable DNA methylation defines a cardiac-specific epigenetic clock
Population study (tot n = 383) | AVR (n = 94) | CABG (n = 289) | Chi-squared p value overall | ||
|---|---|---|---|---|---|
Male | 58 (15.1%) | 229 (59.8%) | 0.0007 | ||
Female | 36 (9.4%) | 60 (15.7%) | |||
BMI ≥ 30 | Male | 11 (12.9%) | Male | 54 (63.5%) | 0.20 |
Female | 6 (7.1%) | Female | 14 (16.5%) | ||
Smoker | Male | 20 (13.8%) | Male | 101 (69.7%) | 0.005 |
Female | 10 (6.9%) | Female | 14 (9.7%) | ||
Former smoker | Male | 0 | Male | 35 (85.4%) | n.a |
Female | 0 | Female | 6 (14.6%) | ||
Congestive heart failure | Male | 5 (33.3%) | Male | 1 (6.7%) | 0.31 |
Female | 8 (53.3%) | Female | 1 (6.7%) | ||
Atrial fibrillation | Male | 13 (29.5%) | Male | 16 (36.4%) | 0.11 |
Female | 11 (25.0%) | Female | 4 (9.1%) | ||
Hypertension | Male | 43 (13.2%) | Male | 203 (62.3%) | 0.0004 |
Female | 29 (8.9%) | Female | 51 (15.6%) | ||
Dyslipidemia | Male | 25 (9.1%) | Male | 182 (66.4%) |  < 0.0001 |
Female | 22 (8.0%) | Female | 45 (16.4%) | ||